[Virus in hemophilia: current status and future perspectives].
Aguilar
C
C
Servicio Regional de Hematología y Hemoterapia, Hospital Miguel Servet, Zaragoza.
Félix Lucía
J
J
D003902:Detergents / Q000494:pharmacology; D004340:Drug Contamination; D016731:Erythema Infectiosum / Q000150:complications / Q000517:prevention & control / Q000635:transmission; D005164:Factor IX / Q000009:adverse effects / Q000302:isolation & purification; D005169:Factor VIII / Q000009:adverse effects / Q000302:isolation & purification; D005544:Forecasting; D006678:HIV / Q000187:drug effects; D015658:HIV Infections / Q000150:complications / Q000517:prevention & control / Q000635:transmission; D006467:Hemophilia A / Q000150:complications* / Q000628:therapy; D006506:Hepatitis A / Q000150:complications / Q000517:prevention & control / Q000635:transmission; D006507:Hepatovirus / Q000502:physiology; D006358:Hot Temperature; D006801:Humans; D012997:Solvents / Q000494:pharmacology; D065227:Transfusion Reaction; D014777:Virus Diseases / Q000150:complications* / Q000517:prevention & control / Q000635:transmission; D014780:Viruses / Q000737:chemistry / Q000145:classification / Q000187:drug effects
D003902:Detergents; D012997:Solvents; D005169:Factor VIII; D005164:Factor IX
Virus en hemofilia: situación actual y perspectivas futuras.